| Download a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
This report:
- Describes various medical applications for nanomaterials including
diagnostics, pharmaceuticals, medical devices and medical imaging
- Determines the current market status for naomaterials and nanodevices used
in medical applications, and makes forecasts over a five-year period from 2008
to
- Includes a thorough patent analysis
- Discusses developments that could affect the long-term market for
nanomaterials and nanodevices in medical applications including environmental
and safety issues.
INTRODUCTION
Hardly a month seems to go by without the announcement of new nanotechnology
developments for medical applications. These developments have the potential
to save many lives and improve the quality of life for countless others living
with various medical ailments.
Study Background
Nanomaterials and other nanotechnologies have already found a variety of
commercial and research applications in medicine, including drug therapies,
drug delivery systems, wound care products, diagnostic tests, and medical
imaging agents. The prospects for future growth in nanomedical applications
are striking.
One recent study found that there were 130 nano-based drugs and delivery
systems, as well as 125 medical devices incorporating nanotechnology in
preclinical, clinical, or commercial development.[1] The number of new
nanomedical applications in the pipeline is so great that it is straining the
capacity of the U.S. Food and Drug Administration (FDA) and other national
agencies that evaluate the effectiveness and safety of such innovations.[2]
The number of products approaching the FDA approval and review process is
likely to grow as new nanotechnology medical applications are developed.
In addition to smart drugs that are more effective and cause fewer side
effects than existing drug therapies, nanotechnology is expected to facilitate
novel approaches to disease diagnosis and prevention. Other nanomedical
applications that are under development may help to improve the lives of
people with severe injuries or medical conditions, ranging from better
implants and prosthetics to brain-machine interfaces that can improve sensory,
motoric, and other functions.
In the even longer term, nanotechnology may be used to construct molecular
systems that are strikingly similar to living systems. These molecular
structures could be the basis for the regeneration or replacement of body
parts that are currently lost to infections, accidents, or diseases.
Study Goals and Objectives
The possibilities of nanomedicine are seemingly almost endless, although
intuition alone tells us that not all of these possibilities are likely to
become medical realities. The goal of this report is to survey nanotechnology
applications in the health care field, identify the applications that appear
to have significant potential in the next 5 to 10 years, and develop
quantitative estimates of their future sales.
The report's approach is similar to that of the BCC report entitled
Nanotechnology: A Realistic Market Assessment (NAN031C) in that it generally
avoids futuristic speculation about nanotechnology applications that might be
possible in the long term. Instead, the report focuses on applications that
BCC expects to make it to market by 2018.
The report's specific objectives support this broad goal. These objectives
include identifying nanotechnology applications in health care that have the
greatest commercial potential in the 2008 to 2018 time frame, identifying
market drivers and evaluating obstacles to their successful commercialization,
and projecting future sales of each application.
Intended Audience
This report is intended especially for nanotechnology marketing executives,
entrepreneurs, investors, venture capitalists, and other readers with a need
to know where the nanotechnology market in the medical field is headed over
the next 5 to 10 years. Other readers who should find the report
particularly valuable include government officials associated with the U.S.
National Nanotechnology Initiative and other state-level programs to promote
the development of the nanotechnology industry. The report's findings and
conclusions should also be of interest to the broader health and
nanotechnology communities.
Scope Of Report
The report addresses the global market for emerging nanotechnology
applications in the medical field, including:
- Basic medical research
- Diagnostics
- Pharmaceuticals
- Medical devices
- Medical imaging
Nanotechnology applications are generally defined as the creation and
utilization of synthetic materials, devices, and systems through the
manipulation of matter at scales of less than 100 nanometers. Based on this
definition, the report covers nanomaterials (e.g., nanoparticles, nanotubes,
nanostructured materials, nanocomposites), nanotools (e.g., scanning probe
microscopes), and nanodevices (e.g., nanosensors).
The study format includes these major elements:
- Executive summary
- Definitions
- Emerging and developmental nanotechnology applications for the medical
field that have the greatest commercial potential through
- Detailed market estimates and projections for each application during the
period from 2007 to
- General assessment of expected market trends in the longer term (i.e.,
2014 to 2018)
- Analysis of industry structure and company profiles
- Patent analysis
Information Sources and Methodology
Projecting the market for emerging technologies, whose commercial potential
has not yet been proven is a challenging task. This is certainly true in the
nanotechnology field, which may help to explain why many analysts choose to
focus on supply-side nanotechnology assessments. However, BCC's objective in
this report is to provide not just a technology assessment, but also a
realistic commercial assessment of the health care-related market for
nanotechnology applications. To accomplish this objective, BCC used a
multiphase approach to identify the nanotechnology applications with the
greatest commercial potential and quantify the market for these applications.
In the first phase of the analysis, BCC identified a long list of potential
nanotechnology applications in health care, including applications that are
still under development. In the second phase, through a literature review and
interviews with industry sources, BCC eliminated those nanotechnology
applications that appear to have little likelihood of making it into
commercial production in the next 5 to 10 years. The result of phase two was a
short list of nanomedical applications with the commercial potential over the
time period covered by this report.
The third phase focused on quantifying the potential market for each
short-listed nanotechnology application and identifying the main prerequisites
for commercial success. Various methodologies and data sources were used to
develop the projections, including trend-line projections, input-output
analysis, and estimates of future demand from industry sources.
Phase Three was composed of two phases: 1) development of near to midterm
(2008 to 2013) projections, and 2) development of longer-term (2014 to 2018)
projections. As previously mentioned, the development of such long-term
projections is a departure from the usual BCC report format. This is
necessitated by the long-time frame for commercialization of many of the
technologies analyzed in this report. Obviously, the projections for the
out-years beyond 2014 are more tentative than the projections for 2008 to 2013.
The specific assumptions and approach used by BCC to develop the
projections-both near/mid-term and long term-for each application are
documented in detail under the various segments addressed. This lets readers
see how the market estimates were developed, and if they so desire, they can
test the impact on the final numbers of changing assumptions regarding such
matters as the date of regulatory approval.
TABLE OF CONTENTS
- Global Medical Markets for Nanoscale Materials and Devices
Chapter- 1: SUMMARY
- SUMMARY TABLE MEDICAL MARKET FOR NANOTECHNOLOGY APPLICATIONS, 2007-2018
- SUMMARY FIGURE MEDICAL MARKET FOR NANOTECHNOLOGY APPLICATION, BY TYPE OF
APPLICATION, 2007-2018 (%)
Chapter- 2: OVERVIEW
- TYPES OF NANOTECHNOLOGY WITH MEDICAL APPLICATIONS
- NANOMATERIALS
- TABLE 1 MAJOR CATEGORIES OF NANOMATERIALS USED IN MEDICAL APPLICATIONS
- TABLE 1 (CONTINUED)
- Solid Nanoparticles
- Hollow Nanoparticles
- Nanoscale Thin Films and Coatings
- Nanostructured Monolithics
- Nanocomposites
- Nanotools
- Nanodevices
- MEDICAL APPLICATIONS OF NANOTECHNOLOGY
- MEDICAL RESEARCH
- TABLE 2 MEDICAL RESEARCH APPLICATIONS OF NANOTECHNOLOGY
- CLINICAL DIAGNOSTICS
- TABLE 3 CLINICAL DIAGNOSTIC APPLICATIONS OF NANOTECHNOLOGY
- PHARMACEUTICALS
- TABLE 4 PHARMACEUTICAL APPLICATIONS OF NANOTECHNOLOGY
- MEDICAL DEVICES
- TABLE 5 MEDICAL DEVICE APPLICATIONS OF NANOTECHNOLOGY
- MEDICAL IMAGING
- TABLE 6 MEDICAL IMAGING APPLICATIONS OF NANOTECHNOLOGY
- MARKET SIZE AND SEGMENTATION
- MARKET SIZE
- FIGURE 1 TRENDS IN GLOBAL MARKET FOR NANOMEDICAL APPLICATIONS, 2007-2018
($ MILLIONS)
- FIGURE 1 (CONTINUED)
- APPLICATION SEGMENTS
- FIGURE 2 GLOBAL NANOMEDICAL MARKET BY TYPE OF APPLICATION, 2007-2013 ($
MILLIONS)
- FIGURE 2 (CONTINUED)
- TABLE 7 MEDICAL MARKET FOR NANOMATERIALS AND NANODEVICES, BY
APPLICATION, THROUGH 2013 ($ MILLIONS)
- NANOTECHNOLOGY SEGMENTS
- TABLE 8 MEDICAL MARKET FOR DIFFERENT TYPES OF NANOTECHNOLOGIES, THROUGH
2018 ($ MILLIONS)
- FIGURE 3 GLOBAL NANOMEDICAL MARKET BY TYPE OF NANOTECHNOLOGY, 2007-2013
($ MILLIONS)
Chapter- 3: MEDICAL RESEARCH MARKET FOR NANOTECHNOLOGY APPLICATIONS, 2007-2018
- SUMMARY
- TABLE 9 MEDICAL RESEARCH MARKET FOR NANOTECHNOLOGY APPLICATIONS, THROUGH
2018 ($ MILLION)
- FIGURE 4 TRENDS IN CLINICAL DIAGNOSTIC MARKET FOR NANOTECHNOLOGY
APPLICATIONS, 2007-2018 ($ MILLIONS)
- TABLE 10 CLINICAL DIAGNOSTIC MARKET FOR NANOTECHNOLOGY APPLICATIONS BY
TYPE OF NANOTECHNOLOGY, THROUGH 2018 ($ MILLIONS)
- FIGURE 5 TRENDS IN MEDICAL RESEARCH MARKET FOR NANOTECHNOLOGY
APPLICATIONS BY TYPE OF NANOTECHNOLOGY, 2007-2018 ($ MILLIONS)
- COMMERCIAL APPLICATIONS
- TABLE 11 MEDICAL RESEARCH MARKETS FOR NANOTECHNOLOGY APPLICATIONS
CURRENTLY IN COMMERCIAL USE, THROUGH 2018 ($ MILLIONS)
- HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 12 GLOBAL MARKET FOR NANO-HPLC APPLICATIONS, THROUGH 2018 ($
MILLIONS)
- MAGNETIC SEPARATIONS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Markets
- TABLE 13 GLOBAL MARKET FOR IRON OXIDE NANOPARTICLES IN BIOMAGNETIC
SEPARATIONS, THROUGH 2018 ($ MILLIONS)
- TRANSFECTON REAGENTS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 14 GLOBAL MARKET FOR DENDRIMER-BASED TRANSFECTON REAGENTS, THROUGH
2018 ($ MILLIONS)
- MEMBRANE SEPARATION
- Nanotechnology Application
- Commercial and Regulatory Status
- Projected Market
- TABLE 15 GLOBAL MARKET FOR NANOMEMBRANES USED IN BIOMEDICAL RESEARCH
APPLICATIONS, THROUGH 2018 ($ MILLIONS)
- NANOMANIPULATORS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Markets
- TABLE 16 GLOBAL MARKET FOR NANOMANIPULATORS IN MEDICAL RESEARCH
APPLICATIONS, THROUGH 2018 ($ MILLIONS)
- PRE-COMMERCIAL AND DEVELOPMENTAL APPLICATIONS
- APTAMER PROTEOMICS ARRAYS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 17 GLOBAL MARKET FOR APTAMER PROTEOMICS ARRAYS, THROUGH 2018 ($
MILLIONS)
Chapter- 4: CLINICAL DIAGNOSTIC MARKET FOR NANOTECHNOLOGY APPLICATIONS, 2017-2018
- SUMMARY
- TABLE 18 CLINICAL DIAGNOSTIC MARKET FOR NANOTECHNOLOGY APPLICATIONS,
THROUGH 2018 ($ MILLIONS)
- FIGURE 6 TRENDS IN CLINICAL DIAGNOSTIC MARKET FOR NANOTECHNOLOGY
APPLICATIONS, 2007-2018 ($ MILLIONS)
- TABLE 19 CLINICAL DIAGNOSTIC MARKET FOR NANOTECHNOLOGY APPLICATIONS BY
TYPE OF NANOTECHNOLOGY, THROUGH 2018 ($ MILLIONS)
- FIGURE 7 CLINICAL DIAGNOSTIC MARKET FOR NANOTECHNOLOGY APPLICATIONS BY
TYPE OF NANOTECHNOLOGY, 2007-2018 ($ MILLION)
- COMMERCIAL APPLICATIONS
- TABLE 20 CLINICAL DIAGNOSTIC MARKETS FOR NANOTECHNOLOGY APPLICATIONS
CURRENTLY IN COMMERCIAL USE, THROUGH 2018 ($ MILLIONS)
- BIOLOGICAL MARKERS AND DETECTION AIDS
- Nanotechnology Applications
- Gold Nanoparticles
- Dendrimers
- Iron Oxide
- Quantum Dots
- Commercial and Regulatory Status
- Projected Market
- TABLE 21 WORLD MARKETS FOR NANOPARTICLES IN BIODETECTION AND LABELING
APPLICATIONS, THROUGH 2018 ($ MILLIONS)
- FIGURE 8 TRENDS NANOPARTICLES USED FOR BIODETECTION AND LABELING
APPLICATIONS, 2007-2018 ($ MILLIONS)
- Colloidal Gold
- Dendrimers
- Iron Oxide
- Quantum Dots
- PRE-COMMERCIAL AND DEVELOPMENTAL APPLICATIONS
- TABLE 22 CLINICAL DIAGNOSTIC MARKETS FOR PRE-COMMERCIAL AND
DEVELOPMENTAL NANOTECHNOLOGY APPLICATIONS, THROUGH 2018 ($ MILLIONS)
- NANOSHELL-BASED WHOLE BLOOD IMMUNOASSAYS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 23 WORLD MARKETS FOR NANOSHELL-BASED REAGENTS USED IN WHOLE BLOOD
IMMUNOASSAYS, THROUGH 2013 ($ MILLIONS)
- SALIVA BASED DIAGNOSTICS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 24 WORLD MARKETS FOR NANOTECHNOLOGY-BASED POC SALIVA TESTS,
THROUGH 2018 ($ MILLIONS)
- NANOWIRE-BASED BIOMARKER SENSORS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 25 WORLD MARKETS FOR NANOWIRE-BASED BIOMARKER POC TESTS, THROUGH
2018 ($ MILLIONS)
- BIOBARCODE ASSAYS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Potential Markets
- TABLE 26 WORLD MARKETS FOR BIOBARCODE-BASED MOLECULAR DIAGNOSTIC TEST
REAGENTS, THROUGH 2018 ($ MILLIONS)
- CARBON NANOTUBE-BASED DNA DETECTOR
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 27 WORLD MARKETS FOR NANOTUBE-BASED DNA PROBES, THROUGH 2018 ($
MILLIONS)
Chapter- 5: PHARMACEUTICAL MARKETS FOR NANOTECHNOLOGY APPLICATIONS, 2017-2018
- PHARMACEUTICAL MARKETS FOR NANOTECHNOLOGY APPLICATIONS, 2017-2018
- SUMMARY
- TABLE 28 PHARMACEUTICAL-RELATED MARKET FOR NANOTECHNOLOGY APPLICATIONS,
THROUGH 2018 ($ MILLIONS)
- FIGURE 9 TRENDS IN PHARMACEUTICAL MARKET FOR NANOTECHNOLOGY
APPLICATIONS, 2007-2018 ($ MILLIONS)
- TABLE 29 PHARMACEUTICAL MARKET FOR NANOTECHNOLOGY APPLICATIONS BY TYPE
OF NANOTECHNOLOGY, THROUGH 2018 ($ MILLIONS)
- FIGURE 10 TRENDS IN PHARMACEUTICAL MARKET FOR NANOTECHNOLOGY
APPLICATIONS BY TYPE OF NANOTECHNOLOGY, 2007-2018 ($ MILLIONS)
- COMMERCIAL APPLICATIONS
- TABLE 30 PHARMACEUTICAL MARKETS FOR NANOTECHNOLOGY APPLICATIONS
CURRENTLY IN COMMERCIAL USE, THROUGH 2018 ($ MILLIONS)
- ENHANCED-SOLUBILITY DRUG COMPOUNDS
- Nanotechnology Applications
- TABLE 31 NANOTECHNOLOGY-BASED APPROACHES TO ENHANCING WATER SOLUBILITY
OF HYDROPHOBIC DRUGS
- Nanocrystal (Elan)
- Commercial and Regulatory Status
- Projected Market
- TABLE 32 ESTIMATED SALES OF COMMERCIAL DRUGS FORMULATED USING ELAN
NANOCRYSTAL TECHNOLOGY, 2007 ($ MILLIONS)
- TABLE 33 GLOBAL MARKET FOR DRUGS FORMULATED USING ELAN NANOCRYSTAL
TECHNOLOGY, THROUGH 2018 ($ MILLIONS)
- NANOLIPOSOME-ENCLOSED CANCER DRUG
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 34 GLOBAL MARKET FOR NANOLIPOSOME-ENCLOSED CANCER DRUGS, THROUGH
2018 ($ MILLIONS)
- NANOPHOSPHOLIPID-BASED HORMONE THERAPIES
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 35 GLOBAL MARKET FOR NANOPHOSPHOLIPID-BASED TRANSDERMAL HORMONE
THERAPIES, THROUGH 2018 ($ MILLIONS)
- APTAMER-BASED AMD THERAPY
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 36 GLOBAL MARKET FOR MACUGEN APTAMER-BASED AMD DRUG, THROUGH 2018
($ MILLIONS)
- PRE-COMMERCIAL AND DEVELOPMENTAL APPLICATIONS
- TABLE 37 PHARMACEUTICAL MARKETS FOR NANOTECHNOLOGY APPLICATIONS
CURRENTLY UNDER DEVELOPMENT, THROUGH 2018 ($ MILLIONS)
- TABLE 37 (CONTINUED)
- MICROBIOCIDAL GEL
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 38 GLOBAL MARKET FOR VIVAGEL DENDRIMER-BASED MICROBIOCIDAL GEL,
THROUGH 2018 ($ MILLIONS)
- BRACHYTHERAPY TREATMENT
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 39 GLOBAL MARKET FOR BRACHYSIL NANOSTRUCTURED BRACHYTHERAPY
PRODUCTS, THROUGH 2018 ($ MILLIONS)
- NON-SMALL-CELL LUNG CANCER SUPPRESSOR
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 40 GLOBAL MARKET FOR NANOPARTICLE-BASED NSCLC THERAPIES, THROUGH
2018 ($ MILLIONS)
- NANOPARTICLE PACLITAXEL
- Nanotechnology Applications
- DO/NDR/02
- NK 105
- Nanoshell-Encapsulated Paclitaxel
- Transferrin-Coated Paclitaxel Nanoparticles
- Commercial and Regulatory Status
- Projected Market
- TABLE 41 GLOBAL MARKET FOR NANOPARTICLE PACLITAXEL THERAPEUTICS, THROUGH
2018 ($ MILLIONS)
- COLLOIDAL GOLD-BASED CANCER THERAPEUTICS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Potential Market
- TABLE 42 GLOBAL MARKET FOR COLLOIDAL GOLD-BASED CANCER THERAPEUTICS,
THROUGH 2018 ($ MILLIONS)
- NANOBOMBS
- Nanotechnology Applications
- Carbon Nanotube Bomb
- Porous Silicon Nanobomb
- Dendrimer Nanobomb
- Dual Chamber Nanobomb
- Commercial and Regulatory Status
- Projected Market
- TABLE 43 GLOBAL MARKET FOR ANTI-CANCER NANOBOMBS, THROUGH 2018 ($
MILLIONS)
Chapter- 6: MEDICAL DEVICE MARKETS FOR NANOTECHNOLOGY APPLICATIONS
- SUMMARY
- TABLE 44 MEDICAL DEVICE MARKETS FOR NANOTECHNOLOGY APPLICATIONS, THROUGH
2018 ($ MILLIONS)
- FIGURE 11 TRENDS IN MEDICAL DEVICE MARKET FOR NANOTECHNOLOGY
APPLICATIONS, 2007-2018 ($ MILLIONS)
- TABLE 45 MEDICAL DEVICE MARKETS FOR NANOTECHNOLOGY APPLICATIONS BY TYPE
OF NANOTECHNOLOGY, THROUGH 2018 ($ MILLIONS)
- FIGURE 12 TRENDS IN MEDICAL DEVICE MARKETS FOR NANOTECHNOLOGY
APPLICATIONS BY TYPE OF NANOTECHNOLOGY, 2007-2018 ($ MILLIONS)
- COMMERCIAL APPLICATIONS
- TABLE 46 MEDICAL DEVICE MARKETS FOR NANOTECHNOLOGY APPLICATIONS
CURRENTLY IN COMMERCIAL USE, THROUGH 2018 ($ MILLIONS)
- BONE SUBSTITUTES
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Markets
- TABLE 47 GLOBAL MARKET FOR NANOTECHNOLOGY-BASED SYNTHETIC BONE
SUBSTITUTES, THROUGH 2018 ($ MILLIONS)
- ANTIMICROBIAL DRESSINGS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- Projected Market (continued)
- TABLE 48 GLOBAL MARKET FOR NANOTECHNOLOGY-BASED ANTIMICROBIAL
APPLICATIONS, THROUGH 2018 ($ MILLIONS)
- SPINTRONIC SENSORS FOR MEDICAL DEVICES
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 49 GLOBAL MARKET FOR SPINTRONICS-BASED MEDICAL SENSORS, THROUGH
2018 ($ MILLIONS)
- SURGICAL TOOLS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 50 GLOBAL MARKET FOR NANOSCALE DIAMOND SURGICAL INSTRUMENT
COATINGS, THROUGH 2018 ($ MILLIONS)
- SUTURE NEEDLES
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 51 GLOBAL MARKET FOR NANOSTRUCTURED STEEL SUTURE NEEDLES, THROUGH
2018 ($ MILLIONS)
- MEDICAL APPAREL
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 52 GLOBAL MARKET FOR NANOSTRUCTURED SILVER YARN FOR MEDICAL
APPAREL, THROUGH 2018 ($ MILLIONS)
- NANOCOMPOSITE MEDICAL TUBING
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Markets
- TABLE 53 GLOBAL MARKET FOR NYLON/CLAY NANOCOMPOSITES IN MEDICAL TUBING
APPLICATONS, THROUGH 2018 ($ MILLIONS)
- MEDICAL DEVICE INFECTION CONTROL
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 54 GLOBAL MARKET FOR SILVER NANOPARTICLE ANTIMICROBIAL COATINGS
FOR MEDICAL DEVICES, THROUGH 2018 ($ MILLIONS)
- PRE-COMMERCIAL AND DEVELOPMENTAL APPLICATIONS
- TABLE 55 MEDICAL DEVICE MARKETS FOR PRE-COMMERCIAL AND DEVELOPMENTAL
NANOTECHNOLOGY APPLICATIONS, THROUGH 2018 ($ MILLIONS)
- TABLE 55 (CONTINUED)
- MRI-SAFE COATINGS FOR MEDICAL DEVICES
- Nanotechnology Applications
- Commercial and Regulatory Status
- Potential Market
- TABLE 56 GLOBAL MARKET FOR NANOTECHNOLOGY-BASED MRI-SAFE COATING
APPLICATIONS, THROUGH 2018 ($ MILLIONS)
- BIOCOMPATIBLE COATINGS FOR MEDICAL DEVICES AND IMPLANTS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Potential Markets
- TABLE 57 GLOBAL MARKET FOR NANOTECHNOLOGY-BASED CORONARY STENT
APPLICATIONS, THROUGH 2018 ($ MILLIONS)
- NANOSTRUCTURED TITANIUM IMPLANTS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 58 GLOBAL MARKET FOR NANOSTRUCTURED TITANIUM IMPLANTS, THROUGH
2018 ($ MILLIONS)
- LONG-LASTING NANOHORN FUEL CELLS FOR MEDICAL DEVICES
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Markets
- TABLE 59 GLOBAL MARKET FOR NANOHORN-BASED FUEL CELLS FOR MEDICAL
IMPLANTS, THROUGH 2018 ($ MILLIONS)
- NANOTUBE-BASED RESPIRATORY MONITORS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 60 GLOBAL SALES OF SPIROMETERS AND CAPNOMETERS, THROUGH 2013 ($
MILLIONS)
- Projected Market (Continued)
- TABLE 61 GLOBAL MARKET FOR NANOTUBE-BASED RESPIRATORY GAS MONITORS,
THROUGH 2018 ($ MILLIONS)
- RETINAL IMPLANTS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- MEDICAL IMAGING MARKETS FOR NANOTECHNOLOGY APPLICATIONS
- SUMMARY
- TABLE 62 MEDICAL IMAGING MARKETS FOR NANOTECHNOLOGY APPLICATIONS,
2007-2018 ($ MILLIONS
- FIGURE 13 TRENDS IN MEDICAL IMAGING MARKET FOR NANOTECHNOLOGY
APPLICATIONS, 2007-2018 ($ MILLIONS)
- TABLE 63 MEDICAL IMAGING MARKETS FOR NANOTECHNOLOGY APPLICATIONS BY TYPE
OF NANOTECHNOLOGY, THROUGH 2018 ($ MILLIONS)
- FIGURE 14 TRENDS IN MEDICAL IMAGING MARKETS FOR NANOTECHNOLOGY
APPLICATIONS BY TYPE OF NANOTECHNOLOGY, 2007-2018 ($ MILLIONS)
- COMMERCIAL APPLICATIONS
- TABLE 64 MEDICAL IMAGING MARKETS FOR NANOTECHNOLOGY APPLICATIONS
CURRENTLY IN COMMERCIAL USE, THROUGH 2018 ($ MILLIONS)
- SUPERPARAMAGNETIC MAGNETIC RESONANCE IMAGING (MRI) CONTRAST AGENTS
- Nanotechnology Applications
- Commercial and Regulatory Status
- TABLE 65 SUPERPARAMAGNETIC IRON OXIDE CONTRAST MEDIA: REGULATORY AND
MARKETING STATUS
- TABLE 65 (CONTINUED)
- Projected Market
- TABLE 66 GLOBAL MARKET FOR NANOPARTICULATE IRON OXIDE USED IN MRI
CONTRAST MEDIA, THROUGH 2018 ($ MILLIONS)
- SCANNING PROBE MICROSCOPE TIPS
- Nanotechnology Applications
- Commercial Status
- Projected Market
- TABLE 67 GLOBAL CARBON NANOTUBES USED IN SCANNING PROBE MICROSCOPE TIPS,
THROUGH 2018 ($ MILLION)
- NANOPARTICLE-BASED OPTICAL IMAGING AGENTS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Markets
- TABLE 68 GLOBAL MARKET FOR NANOPARTICLE-BASED FLUORESCENT IMAGING
AGENTS, THROUGH 2018 ($ MILLIONS)
- PRE-COMMERCIAL AND DEVELOPMENTAL APPLICATIONS
- TABLE 69 MEDICAL IMAGING MARKETS FOR PRE-COMMERCIAL AND DEVELOPMENTAL
NANOTECHNOLOGY APPLICATIONS, THROUGH 2018 ($ MILLIONS)
- NANOTUBE FIELD EMISSION X-RAY TUBES
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Markets
- TABLE 70 GLOBAL MARKET FOR CARBON NANOTUBE FIELD-EMITTER X-RAY TUBES,
THROUGH 2018 ($ MILLIONS)
- ORGANIC LIGHT-EMITTING DIODES SURGICAL DISPLAYS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 71 GLOBAL MARKET FOR OLEDS IN SURGICAL DISPLAYS, THROUGH 2018 ($
MILLIONS)
- METAL NANOSHELL PHOTONICS-BASED IMAGING CONTRAST AGENTS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Markets
- TABLE 72 GLOBAL MARKET FOR METAL NANOSHELLS IN IMAGING AND THERAPEUTIC
APPLICATIONS, THROUGH 2018 ($ MILLIONS)
- APTAMER MOLECULAR IMAGING AGENTS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Markets
- TABLE 73 GLOBAL MARKET FOR APTAMER IMAGING AGENTS IN MOLECULAR IMAGING,
THROUGH 2018 ($ MILLIONS)
- FULLERENE MAGNETIC RESONANCE IMAGING AGENTS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Projected Market
- TABLE 74 GLOBAL MARKET FOR FULLERENE-BASED IMAGING AGENTS IN MRI,
THROUGH 2018 ($ MILLIONS)
- GOLD NANOROD IMAGING AGENTS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Potential Markets
- TABLE 75 GLOBAL MARKET FOR GOLD NANOROD-BASED IMAGING AGENTS, THROUGH
2018 ($ MILLIONS)
- OTHER NANOSCALE IMAGING AGENTS
- Nanotechnology Applications
- Commercial and Regulatory Status
- Potential Markets
Chapter- 7: INDUSTRY STRUCTURE
- FIRM SIZE
- FIGURE 15 NANO-MEDICAL FIRMS BY SIZE (PERCENTAGE OF TOTAL COMPANIES
ANALYZED)
- MAIN PRODUCT LINES
- FIGURE 16 NANO-MEDICAL FIRMS BY MAIN PRODUCT LINE (PERCENTAGE OF TOTAL
COMPANIES ANALYZED)
- NANOMEDICAL FIRMS BY NATIONALITY
- FIGURE 17 NANOMEDICAL FIRMS BY MAIN PRODUCT LINE (PERCENTAGE OF TOTAL
COMPANIES ANALYZED)
Chapter- 8: APPENDIX 1: COMPANY PROFILES
- AAP IMPLANTATE AG
- ACRYMED, INC.
- ALZA CORP.
- AMAG PHARMACEUTICALS, INC.
- ANGSTROM MEDICA, INC.
- APHIOS CORP.
- APPLIED NANODETECTORS LTD.
- APPLIED NEUROSOLUTIONS, INC.
- BANGS LABORATORIES, INC.
- BERKELEY ADVANCED BIOMATERIALS, INC.
- BIOPHAN TECHNOLOGIES, INC.
- CAPSULUTION NANOSCIENCE AG
- CYTIMMUNE SCIENCES, INC.
- DEBIOTECH SA
- DENDRITECH, INC.
- DENDRITIC NANOTECHNOLOGIES INC.
- DIONEX CORP.
- DOW CHEMICAL CO.
- DYNAL BIOTECH ASA
- EKSIGENT TECHNOLOGIES, LLC
- ELAN CORPORATION, PLC
- EMD CHEMICALS, INC.
- EVIDENT TECHNOLOGIES
- FLAMEL TECHNOLOGIES SA
- FOSTER CORP.
- GESELLSCHAFT FÜR DIAMANTPRODUKE MBH
- HYOSUNG CORP.
- INFRAMAT CORP.
- INTEGRATED NANO-TECHNOLOGIES, LLC
- INTROGEN THERAPEUTICS, INC.
- INVITROGEN CORP.
- JR NANOTECH PLC
- MAD CITY LABS, INC.
- MAGNABIOSCIENCES LLC
- MESOSYSTEMS/ICX
- MICROCOSM, INC.
- MICRO-TECH SCIENTIFIC INC.
- MICROMOD PARTIKELTECHNOLOGIE GMBH
- MIV THERAPEUTICS, INC.
- NANOCARRIER CORP., LTD.
- NANOMIX, INC.
- NANOPEUTICS SRO
- NANOPROBES, INC.
- NANO SCIENCE DIAGNOSTICS, INC.
- NANOSPECTRA BIOSCIENCES, INC.
- NANOSPHERE, INC.
- NOVAVAX, INC.
- NPOINT, INC.
- NUCRYST PHARMACEUTICALS
- NVE CORP.
- ORASURE TECHNOLOGIES, INC.
- ORTHOVITA, INC.
- OSI PHARMACEUTICALS, INC.
- OXONICA, LTD.
- PHARMASOL GMBH
- POLYSCIENCES INC.
- PSIVIDA INC.
- QUIAGEN N.V.
- SALVONA LLC
- SANDVIK MATERIALS TECHNOLOGY AB
- SIMPORE INC.
- SKYEPHARMA PLC
- SOMALOGIC, INC.
- SPIRE CORP.
- STARPHARMA PTY LTD
- SURFACINE DEVELOPMENT CO. LLC
- TEGO BIOSCIENCES CORP.
- VISEN MEDICAL INC.
- VISTA THERAPEUTICS, INC.
- FIGURE 18 BIOMEDICAL MARKET FOR NANOWIRE SENSORS (%)
- XINTEK, INC.
- ZYVEX CORP.
Chapter- 9: APPENDIX 2: PATENT ANALYSIS
- PATENTS BY TYPE OF APPLICATION
- FIGURE 19 U.S. NANO-MEDICAL PATENTS BY APPLICATION SEGMENT (PERCENTAGE
OF IDENTIFIED PATENTS ISSUED THROUGH JUNE 1, 2008)
- FIGURE 19 (CONTINUED)
- MAJOR IP PORTFOLIOS
- TABLE 76 MAJOR HOLDERS OF US NANOMEDICAL PATENTS (NUMBER OF PATENTS HELD
AS OF JUNE 1, 2008)
|
